References and Notes
1a
Metzger JV.
Comprehensive
Heterocyclic Chemistry
Vol. 6:
Katritzky AR.
Rees CW.
Pergamon;
Oxford:
1984.
p.235-331
1b
Dondoni A.
Merino P.
Comprehensive
Heterocyclic Chemistry II
Vol. 3:
Katritzky AR.
Rees CW.
Scriven EFV.
Elsevier
Science;
Oxford:
1996.
p.373-474
1c
Boden CDJ.
Pattenden G.
Ye T.
Synlett
1995,
417
1d
Wipf P.
Chem.
Rev.
1995,
95:
2115
1e
Dondoni A.
Synthesis
1998,
1681
1f
Potewar TM.
Ingale SA.
Srinivasan KV.
Tetrahedron
2007,
63:
11066
1g
Yadav JS.
Reddy BVS.
Rao YG.
Narsaiah AV.
Tetrahedron Lett.
2008,
49:
2381
1h
Potewar TM.
Ingale SA.
Srinivasan KV.
Tetrahedron
2008,
64:
5019
2a
Haviv F.
Ratajczyk JD.
DeNet RW.
Kerdesky
FA.
Walters RL.
Schmidt SP.
Holms JH.
Young PR.
Carter GW.
J. Med. Chem.
1988,
31:
1719
2b
Patt WC.
Hamilton HW.
Taylor MD.
Ryan MJ.
Taylor DG.
Connolly CJC.
Doherty AM.
Klutchko
SR.
Sircar I.
Steinbaugh BA.
Batley BL.
Painchaud
CA.
Rapundalo ST.
Michniewicz BM.
Olson SCJ.
J.
Med. Chem.
1992,
35:
2562
2c
Tsuji K.
Ishikawa H.
Bioorg. Med. Chem. Lett.
1994,
4:
1601
2d
Bell FW.
Cantrell AS.
Hoegberg M.
Jaskunas SR.
Johansson
NG.
Jordon CL.
Kinnick MD.
Lind P.
Morin JM.
Noreen R.
Oberg B.
Palkowitz JA.
Parrish CA.
Pranc P.
Sahlberg C.
Ternansky RJ.
Vasileff RT.
Vrang L.
West SJ.
Zhang H.
Zhou XX.
J. Med. Chem.
1995,
38:
4929
3a
Hantzsch A.
Weber JH.
Ber.
Dtsch. Chem. Ges.
1887,
20:
3118
3b
Wiley RH.
Behr LC.
Org.
Rec.
1951,
6:
367
4a
Koser GF.
Wettach RH.
J. Org. Chem.
1977,
42:
1476
4b
Moriarty RM.
Vaid RK.
Hopkins TE.
Vaid BK.
Prakash O.
Tetrahedron Lett.
1990,
31:
201
4c
Moriarty RM.
Vaid RK.
Duncan MP.
Levy SG.
Prakash O.
Goyal S.
Synthesis
1992,
845
4d
Prakash O.
Goyal S.
Synthesis
1992,
629
4e
Prakash O.
Rani N.
Goyal S.
J.
Chem. Soc., Perkin Trans. 1
1992,
707
4f
Prakash O.
Saini N.
Sharma PK.
Synlett
1994,
221
4g
Ueno M.
Nabana T.
Togo H.
J.
Org. Chem.
2003,
68:
6424
4h
Ueno M.
Togo H.
Synthesis
2004,
2673
5
Wipf P.
Venkatraman S.
J. Org. Chem.
1996,
61:
8004
6a
Togo H.
Hoshina Y.
Muraki T.
Nakayama H.
Yokoyama M.
J. Org. Chem.
1998,
63:
5193
6b
Katohgi M.
Togo H.
Yamaguchi K.
Yokoyama M.
Tetrahedron
1999,
55:
14885
6c
Harada Y.
Togo H.
Yokoyama M.
J. Org. Chem.
2000,
65:
926
6d
Misu Y.
Togo H.
Org. Biomol. Chem.
2003,
1:
1342
6e
Akiike J.
Yamamoto Y.
Togo H.
Synlett
2007,
2168
6f
Kawano Y.
Togo H.
Synlett
2008,
217
7
Koser GF.
Sun G.
Porter CW.
Youngs WJ.
J. Org. Chem.
1993,
58:
7310
8
Typical Procedure
for Preparation of 1
H
-1-(1′-Hexynyl)-5-methyl-1,2,3-benziodoxathiole
3,3-Dioxide
A mixture of 1H-1-hydroxy-5-methyl-1,2,3-benziodoxa-thiole
3,3-dioxide (5 mmol), PTSA˙H2O
(5 mmol), and 1-hexyne (25 mmol) in MeCN (40 mL) was refluxed for
20 h. After removal of the solvent to obtain an oil, a solution
of the oil in CHCl3 (200 mL) was washed with 5% NaHCO3 (80 mL)
and H2O (3 × 50 mL), and was
concentrated to a solid. Recrystallization of the solid with a mixture
of CH2Cl2 (30 mL), Et2O (100 mL),
and hexane (60 mL) gave 1H-1-(1′-hexynyl)-5-methyl-1,2,3-benziodoxathiole
3,3-dioxide in 53% yield.
1
H
-1-(1′-Hexynyl)-5-methyl-1,2,3-benziodoxathiole
3,3-Dioxide (R =
n
-Bu)
Mp
164-166 ˚C (dec.); lit.7 179-181 ˚C
(dec.). IR (Nujol): 2166 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 8.01(s,
1 H), 7.92 (d, J = 8.5
Hz, 1 H), 7.47 (d, J = 8.7
Hz, 1 H), 2.73 (t, J = 7.2
Hz, 2 H), 2.50 (s, 3 H), 1.61-1.74 (m, 2 H), 1.43-1.55
(m, 2 H), 0.98 (t, J = 7.4
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 143.7, 141.6, 135.1,
130.8, 126.8, 115.5, 105.8, 29.9, 28.5, 22.1, 20.8, 20.6, 13.5.
1
H
-1-(1′-Octynyl)-5-methyl-1,2,3-benziodoxathiole
3,3-Dioxide (R =
n
-C
6
H
13
)
Mp
150 ˚C (dec.); lit.7 152-154 ˚C
(dec.). IR (Nujol): 2168 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 8.04
(s, 1 H), 7.90 (d, J = 8.7
Hz, 1 H), 7.48 (dd, J = 1.6,
8.6 Hz, 1 H), 2.73 (t, J = 7.1
Hz, 2 H), 2.51 (s, 3 H), 1.64-1.74 (m, 2 H), 1.42-1.52
(m, 2 H), 1.30-1.40 (m, 4 H), 0.92 (t, J = 7.0
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 143.8, 141.5, 135.0, 130.8,
126.6, 115.5, 105.8, 31.1, 28.5, 28.4, 27.8, 22.4, 20.9, 20.7, 14.0.
1
H
-1-(1′-Phenylethynyl)-5-methyl-1,2,3-benziodoxa-thiole
3,3-Dioxide (R = Ph)
Mp
217-219 ˚C (dec.); lit.7 221-223 ˚C
(dec.). IR (Nujol): 2160 cm-¹. ¹H
NMR (400 MHz, DMSO-d
6, TMS): δ = 8.12 (d, J = 8.4, 1
H), 7.76-7.81(m, 3 H), 7.53-7.67 (m, 4 H), 2.45
(s, 3 H). ¹³C NMR (100 MHz, DMSO-d
6, TMS): δ = 142.6,
142.4, 135.0, 133.0, 131.6, 129.1, 129.1, 128.9, 119.4, 107.7, 107.2,
41.3, 20.2.
Typical Procedure for Preparation
of Thiazoles
To a solution of thiobenzamide (0.48
mmol) in THF (2 mL) were added K2CO3 (0.92
mmol) and 1H-1-(1′-phenyl-ethynyl)-5-methyl-1,2,3-benziodoxathiole
3,3-dioxide (0.4 mmol). The obtained mixture was stirred at 45 ˚C
overnight under argon atmosphere. After the reaction, the mixture
was filtered to remove potassium 2-iodo-5-methyl-benzene-sulfonate
quantitatively. After evaporation of the filtrate, the residue was
chromatographed on SiO2 (eluent: hexane-CHCl3,
1:1) to afford pure 1,4-diphenylthiazole in 65% yield.
2,4-Diphenylthiazole
Mp 91-92 ˚C;
lit.¹0 91-92 ˚C. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 7.98-8.09
(m, 4 H), 7.41-7.51 (m, 6 H), 7.35 (t, J = 7.4
Hz, 1 H).
Regeneration of Potassium
2-Iodo-5-methylbenzene-sulfonate to 1
H
-1-Hydroxy-5-methyl-1,2,3-benziod-oxathiole
3,3-Dioxide
Hydrogen peroxide (33%, 1.3 mL)
was added dropwise to a solution of acetic anhydride (1.2 mL) at
0 ˚C. The obtained mixture was stirred overnight. After
the reaction, the mixture was added dropwise to a stirred mixture
of potassium
2-iodo-5-methylbenzenesulfonate (2.4 mmol)
in AcOH (4 mL) and concd H2SO4 (1.2 mL) while
keeping the temperature at 10-15 ˚C. The mixture
was stirred at this temperature for 1 h and overnight at r.t. After
the reaction, the precipitate was filtered to give 1H-1-hydroxy-5-methyl-1,2,3-benziodoxathiole
3,3-dioxide in 50-60% yield.
2-Phenyl-4-butylthiazole
Oil.
IR(neat): 2956, 2929, 2859, 1516, 1498, 1460, 1436, 1244, 1004,
763, 689 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 7.93
(dd, J = 1.4,
8.0 Hz, 2 H), 7.38-7.45 (m, 3 H), 6.86 (s, 1 H), 2.83 (t, J = 7.8 Hz,
2 H), 1.70-1.80 (m, 2 H), 1.37-1.49 (m, 2 H),
0.96 (t, J = 7.4
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 167.4, 158.9, 133.9,
129.7, 128.8, 126.5, 112.6, 31.4, 31.3, 22.4, 13.9. HRMS-FAB:
m/z calcd for C13H16NS [M + H]:
218.1003; found: 218.1006.
2-Methyl-4-butylthiazole
Oil.
IR(neat): 3427, 2956, 2929, 2859, 1637, 1523, 1457, 1183, 1133,
730, 560, 526 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 6.69
(s, 1 H), 2.67-2.76 (m, 5 H), 1.62-1.73 (m, 2
H), 1.32-1.44 (m, 2 H), 0.93 (t, J = 7.4
Hz, 3 H).¹³C NMR (100 MHz, CDCl3,
TMS): δ = 165.2, 157.3, 111.9,
31.4, 31.2, 22.4, 19.1, 13.9. HRMS-FAB: m/z calcd
for C8H14NS [M + H]:
156.0847; found: 156.0837.
2-(4-Methylphenyl)-4-butylthiazole
Oil.
IR(neat): 2955, 2928, 2859, 1509, 1457, 1246, 1007, 818, 735, 711
cm-¹. ¹H NMR (400
MHz, CDCl3, TMS): δ = 7.82
(d, J = 8.2
Hz, 2 H), 7.22 (d, J = 8.0
Hz, 2 H), 6.82 (s, 1 H), 2.81 (t, J = 7.7
Hz, 2 H), 2.38 (s, 3 H), 1.69-1.79 (m, 2 H), 1.36-1.48
(m, 2 H), 0.96 (t, J = 7.4
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 167.6, 158.7, 139.8,
131.3, 129.5, 126.4, 112.1, 31.4, 31.3, 22.4, 21.4, 13.9. HRMS-FAB: m/z calcd for C14H18NS [M + H]:
232.1160; found: 232.1161.
2-(4-Methoxyphenyl)-4-butylthiazole
Oil.
IR(neat): 2859 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 7.87
(d, J = 8.9
Hz, 2 H), 6.94 (d, J = 9.0
Hz, 2 H), 6.79 (s, 1 H), 3.85 (s, 3 H), 2.81 (t, J = 7.7
Hz, 2 H), 1.68-1.80 (m, 2 H), 1.36-1.48 (m, 2
H), 0.96 (t, J = 7.3
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 167.5, 161.0, 158.7,
128.1, 127.1, 114.3, 111.8, 55.5, 31.6, 31.5, 22.6, 14.1. HRMS-FAB: m/z calcd for C14H18NOS [M + H]: 248.1109;
found: 248.1119.
2-(4-Nitrophenyl)-4-butylthiazole
Mp
47-48 ˚C. IR (Nujol): 1522, 1345, 851 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 8.29
(d, J = 8.9
Hz, 2 H), 8.11 (d, J = 9.2
Hz, 2 H), 7.03 (s, 1 H), 2.85 (t, J = 7.7
Hz, 2 H), 1.71-1.81 (m, 2 H), 1.38-1.49 (m, 2
H), 0.97 (t, J = 7.4
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 164.2, 160.1, 148.2,
139.4, 127.0, 124.2, 115.0, 31.3, 22.3, 13.9. HRMS-FAB: m/z calcd for C13H15N2O2S [M + H]:
263.0854; found: 263.0838.
2-Amino-4-butylthiazole
Oil.
IR (Nujol): 3436, 1607, 1521, 1113, 696 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 6.08
(s, 1 H), 4.91 (s, 2 H), 2.53 (t, J = 7.8
Hz, 2 H), 1.56-1.68 (m, 2 H), 1.30-1.43 (m, 2
H), 0.92 (t, J = 7.4
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3, TMS): δ = 167.3,
102.5, 102.5, 31.7, 31.2, 22.7, 14.2. HRMS-FAB: m/z calcd for C7H13N2S [M + H]:
157.0799; found: 157.0811.
2-Phenyl-4-hexylthiazole
Oil.
IR(neat): 2926, 2856, 1517, 1458, 1239, 1003, 763, 689 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 7.94
(dd, J = 1.7,
7.8 Hz, 2 H), 7.36-7.47 (m, 3 H), 6.87 (s, 1 H), 1.70-1.82
(m, 2 H), 1.27-1.47 (m, 6 H), 0.89 (t, J = 7.1
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 167.4, 158.9, 133.9, 129.7,
128.8, 126.5, 112.6, 31.7, 31.7, 29.2, 29.0, 22.6, 14.1. HRMS-FAB: m/z calcd for C15H20NS [M + H]:
246.1316; found: 246.1315.
2-Methyl-4-hexylthiazole
Oil.
IR(neat): 2955, 2926, 2856, 1523, 1457, 1183, 728 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 6.69
(s, 1 H), 2.67-2.75 (m, 5 H), 1.62-1.75 (m, 2
H), 1.23-1.45 (m, 6 H), 0.88 (t, J = 7.0
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 165.2, 157.4, 111.9,
31.6, 31.6, 29.2, 29.0, 22.6, 19.1, 14.1. HRMS-FAB: m/z calcd for C10H18NS [M + H]: 184.1160;
found: 184.1167.
2-(4-Methylphenyl)-4-hexylthiazole
Oil.
IR(neat): 2926, 2856, 1509, 1457, 1247, 1005, 817, 711 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 7.82
(d, J = 8.3
Hz, 2 H), 7.22 (d, J = 7.8
Hz, 2 H), 6.82 (s, 1 H), 2.80 (t, J = 7.6
Hz, 2 H), 2.38 (s, 3 H), 1.70-1.81 (m, 2 H), 1.27-1.46
(m, 6 H), 0.89 (t, J = 7.1
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 167.6, 158.7, 139.9,
131.3, 129.5, 126.4, 112.1, 31.7, 31.7, 29.2, 29.0, 22.6, 21.4,
14.1. HRMS-FAB: m/z calcd
for C16H22NS [M + H]:
260.1473; found: 260.1493.
2-(4-Methoxyphenyl)-4-hexylthiazole
Oil.
IR(neat): 2855 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 7.87
(d, J = 9.0
Hz, 2 H), 6.94 (d, J = 8.8
Hz, 2 H), 6.79 (s, 1 H), 3.85 (s, 3 H), 2.80 (t, J = 7.8
Hz, 2 H), 1.69-1.80 (m, 2 H), 1.25-1.45 (m, 6
H), 0.89 (t, J = 6.9
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 160.8, 158.6, 134.0,
127.9, 126.9, 114.1, 111.7, 55.4, 31.7, 31.7, 29.2, 29.0, 22.6,
14.1. HRMS-FAB: m/z calcd
for C16H22NOS [M + H]:
276.1422; found: 276.1401.
2-(4-Nitrophenyl)-4-hexylthiazole
Mp
45-46 ˚C. IR (Nujol): 1523, 1339, 852 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 8.28
(d, J = 8.8
Hz, 2 H), 8.10 (d, J = 9.1
Hz, 2 H), 7.03 (s, 1 H), 2.84 (t, J = 7.8
Hz, 2 H), 1.72-1.81 (m, 2 H), 1.30-1.45 (m, 6
H), 0.90 (t, J = 7.8
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 164.2, 160.1, 148.2,
139.4, 127.0, 124.2, 115.0, 31.6, 31.6, 29.1, 28.9, 22.6, 14.1.
HRMS-FAB: m/z calcd
for C15H19N2O2S [M + H]:
291.1167; found: 291.1169.
2-Amino-4-hexylthiazole
Mp
45-46 ˚C. IR (Nujol): 3432, 3235, 1606, 1508,
1103, 706 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 6.08
(s, 1 H), 4.92 (s, 2 H), 2.52 (t, J = 6.9
Hz, 2 H), 1.56-1.68 (m, 2 H), 1.24-1.39 (m, 6
H), 0.88 (t, J = 6.9
Hz, 3 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 167.0, 153.7, 102.2,
31.7, 31.6, 29.0, 28.7, 22.6, 14.1. HRMS-FAB: m/z calcd for C9H17N2S [M + H]:
185.1112; found: 185.1106.
2-Phenyl-4-butylthiazole
Oil.
IR(neat): 2956, 2929, 2859, 1516, 1498, 1460, 1436, 1244, 1004,
763, 689 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 7.93
(dd, J = 1.4,
8.0 Hz, 2 H), 7.38-7.45 (m, 3 H), 6.86 (s, 1 H).
2-Methyl-4-phenylthiazole
Mp 60 ˚C;
lit.4h 64 ˚C. ¹H NMR (400
MHz, CDCl3, TMS): δ = 7.87
(d, J = 8.3
Hz, 2 H), 7.41 (t, J = 7.5
Hz, 2 H), 7.32 (t, J = 7.5
Hz, 1 H), 7.31 (s, 1 H), 2.78 (s, 3 H).
2-(4-Methylphenyl)-4-phenylthiazole
Mp
126 ˚C. IR (Nujol): 974, 815, 741, 690, 676 cm-¹. ¹H NMR
(400 MHz, CDCl3, TMS): δ = 8.00
(d, J = 8.2
Hz, 2 H), 7.94 (d, J = 8.2
Hz, 2 H), 7.41-7.48 (m, 3 H), 7.35 (t, J = 7.3
Hz, 1 H), 7.26 (d, J = 6.5
Hz, 2 H), 2.41 (s, 3 H). ¹³C NMR (100
MHz, CDCl3, TMS): δ = 168.0,
156.1, 140.3, 134.6, 131.1, 129.6, 128.7, 128.1, 126.5, 126.4, 112.1,
21.4. HRMS-FAB: m/z calcd
for C16H14NS [M + H]:
252.0847; found: 252.0851.
2-(4-Methoxyphenyl)-4-phenylthiazole
Mp
97-98 ˚C. IR (Nujol): 1256, 1173, 979, 833, 738
cm-¹. ¹H NMR (400
MHz, CDCl3, TMS): δ = 7.96-8.02
(m, 4 H), 7.40-7.48 (m, 3 H), 7.34 (t, J = 7.4
Hz, 1 H), 6.98 (d, J = 8.9 Hz,
2 H), 3.88 (s, 3 H). ¹³C NMR (100 MHz,
CDCl3, TMS): δ = 177.6,
161.4, 134.9, 133.6, 128.9, 128.3, 127.0, 126.6, 115.0, 114.5, 111.9,
55.7. HRMS-FAB: m/z calcd
for C16H14NOS [M + H]:
268.0796; found: 268.0802.
2-(4-Nitrophenyl)-4-phenylthiazole
Mp
164-165 ˚C. IR (Nujol): 1514, 1339, 849 cm-¹. ¹H
NMR (400 MHz, CDCl3, TMS): δ = 8.33
(d, J = 8.9
Hz, 2 H), 8.22 (d, J = 8.9
Hz, 2 H), 8.00 (d, J = 8.2
Hz, 2 H), 7.63 (s, 1 H), 7.48 (t, J = 7.4
Hz, 2 H), 7.40 (t, J = 7.4
Hz, 1 H). ¹³C NMR (100 MHz, CDCl3,
TMS): δ = 164.8, 157.3, 148.4,
139.1, 133.9, 128.9, 128.7, 127.1, 126.5, 124.3, 114.6. HRMS-FAB: m/z calcd for C15H11N2O2S [M + H]:
283.0541; found: 283.0547.
2-Amino-4-phenylthiazole
Mp
145-147 ˚C. IR (Nujol): 3433, 1595, 1518, 1038,
714 cm-¹. ¹H NMR
(400 MHz, CDCl3, TMS): δ = 7.78
(d, J = 8.0
Hz, 2 H), 7.38 (t, J = 7.6
Hz, 2 H), 7.29 (t, J = 7.4
Hz, 1 H), 6.73 (s, 1 H), 5.03 (s, 2 H). ¹³C
NMR (100 MHz, CDCl3, TMS): δ = 167.0,
151.3, 134.6, 128.6, 127.7, 126.0, 102.9. HRMS-FAB: m/z calcd for C9H9N2S [M + H]: 177.0486;
found: 177.0485.
9
Singh CB.
Ghosh H.
Murru S.
Patel BK.
J. Org. Chem.
2008,
73:
2924
10
Ishida M.
Nakanishi H.
Kato S.
Chem.
Lett.
1984,
1691